![Paul B. Knight](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul B. Knight
Director/Board Member at Molecular Diagnostics & Therapeutics, Inc.
Profile
Paul B.
Knight has been a Director of Molecular Diagnostics & Therapeutics, Inc. since August 2000.
He is President of Transwestern Financial Advisors.
Mr. Knight has experience in capital management, financial forecasting, preparation of financial statements, and overseeing SEC filings and requirements
Paul B. Knight active positions
Companies | Position | Start |
---|---|---|
Molecular Diagnostics & Therapeutics, Inc.
![]() Molecular Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Molecular Diagnostics & Therapeutics, Inc. manufactures and distributes nuclear medicines. Its products include sodium iodide, palladium, thallium, thallous chloride, technetium and pet products. The company on February 19, 1992 and is headquartered in Longmont, CO. | Director/Board Member | 2000-07-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Molecular Diagnostics & Therapeutics, Inc.
![]() Molecular Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Molecular Diagnostics & Therapeutics, Inc. manufactures and distributes nuclear medicines. Its products include sodium iodide, palladium, thallium, thallous chloride, technetium and pet products. The company on February 19, 1992 and is headquartered in Longmont, CO. | Health Technology |
- Stock Market
- Insiders
- Paul B. Knight